Dr. Bizargity is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
90 Bergen St
4650 Sunset Blv
Newark, NJ 07103Phone+1 973-972-3300
Summary
- Dr. Peyman Bizargity is a medical geneticist in Newark, NJ and is affiliated with Rutgers University. He received his medical degree from Marmara University Faculty of Medicine and has been in practice for 26 years. He specializes in clinical genetics.
Education & Training
Baylor College of MedicineFellowship, Medical Genetics and Genomics, 2016 - 2018
Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Pathology-Anatomic and Clinical, 2013 - 2016
Marmara UniversityPhD, Immunology, 1998 - 2004
Marmara Univ- Fac MedClass of 1998
Certifications & Licensure
NY State Medical License 2018 - 2026
NJ State Medical License 2023 - 2025
CA State Medical License 2022 - 2024
PA State Medical License 2016 - 2016- American Board of Medical Genetics and Genomics Clinical Genetics and Genomics
Publications & Presentations
PubMed
- A late presentation ofmyopathy presenting as sleep hypoventilation in the setting of acute demyelinating encephalomyelitis.Virginia Stringel, Peyman Bizargity, Emma Laureta, Sanjeev Kothare
Journal of Clinical Sleep Medicine. 2022-11-01 - 1 citationsA homozygous splice variant in ATP5PO, disrupts mitochondrial complex V function and causes Leigh syndrome in two unrelated families.Mythily Ganapathi, Gaelle Friocourt, Naig Gueguen, Marisa W Friederich, Gerald Le Gac
Journal of Inherited Metabolic Disease. 2022-09-01 - A Rare Case Report of 17q23.1q23.2 Microdeletion With Homozygosity of 11p11.2q13.4 in a Newborn.Sindhu Barola, Allison M Parrill, Samaan Mahmoudzadeh, Peyman Bizargity, Rita Verma
Cureus. 2022-03-01
Research History
- Postdoctoral PositionChildrens Hospital Boston, Harvard University Investigating the immunosuppressive effect of the enzyme Indoleamine 2,3 Dioxygenase. Investigating the immunosuppressive effect of the drug Pirfenidone.2008 - 2011
- Postdoctoral positionUniversity of Vermont Fetomaternal tolerance and immune system changes in pregnancy2004 - 2008
Other Languages
- Turkish, Farsi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
